Neuroscience company lists on IEX and AIM

London-based neuroscience company Amarin has listed on the AIM Market of the London Stock Exchange and the IEX Market of the Irish Stock Exchange.

Amarin will retain its primary listing on NASDAQ.

Amarin did not seek any additional capital as part of the listing process. It is already funded with $33m (€25.9m) of cash as at 31 March 2006.